Today: 21 July 2026
Sunrise Energy Metals share price slips after feasibility study update puts ASX:SRL back in play
3 March 2026
2 mins read

Sunrise Energy Metals share price slips after feasibility study update puts ASX:SRL back in play

Sydney, March 3, 2026, 18:48 AEDT — After-hours

  • Shares of Sunrise Energy Metals slipped 3.6% after the company published its latest feasibility study update for the Syerston scandium project.
  • The company is putting development capital at roughly US$120 million, eyeing mid-2028 for scandium oxide production to begin.
  • Investors have their eyes on a funding package and are awaiting a board final investment decision, which is anticipated sometime in the second half of 2026.

Sunrise Energy Metals Ltd dropped 3.6% to close at A$7.69 on Tuesday, slipping after the company posted an updated feasibility study for its Syerston scandium project and resumed trading following a suspension. Shares ranged from A$7.03 up to A$10.15 through the session.

This update lands some hard figures on a project Sunrise is trying to finance and get off the ground, in a market where buyers are increasingly demanding traceable supply. For a small-cap developer, that feasibility study is the key paper—lenders and potential customers look there first, even if they might quibble with the assumptions.

The timing’s notable: “critical minerals” isn’t just a buzzword anymore, it’s a procurement headache. Scandium itself is a specialty metal, most often traded as scandium oxide (Sc2O3), and goes into aluminium alloys, plus a handful of fuel-cell and semiconductor uses. Sunrise, for its part, is touting Syerston as an unusually large Western source.

Sunrise outlined a plan for annual output of 60 tonnes of high-purity scandium oxide, pegging upfront capital at roughly US$120 million. The company is estimating “C1” cash costs at US$534 per kilogram over a 32-year mine life, aiming to kick off commercial production by mid-2028. Finclear News

According to the release, co-chair Robert Friedland described scandium as “indispensable”. CEO Sam Riggall, for his part, called the feasibility study a “pivotal moment” as Western customers start searching for non-Chinese supply. Finclear News

The ASX announced it’s removing the trading halt on Sunrise’s securities now that the company has put out its feasibility study update.

Sunrise highlighted an earlier letter of interest from the U.S. Export-Import Bank—a potential source of up to US$67 million in project debt funding. But the company also reiterated that any final loan is still subject to a full application process and due diligence.

Supply security is front and center in Sunrise’s pitch. After China slapped export controls on a string of medium and heavy rare earths—including products linked to scandium—back in April 2025, the vulnerability for buyers relying on Chinese supply came into sharp focus.

After a tough stretch, Sunrise shares have tumbled roughly 29% from their A$10.90 close just seven days back, according to delayed pricing.

Plenty could derail this. Everything depends on scandium prices holding up—and Sunrise still needs to secure debt and equity on terms that actually work. Cost overruns or any holdup on the final investment decision would set the timeline back. If demand for specialty metals softens, the financing window could narrow fast.

Looking ahead to the next session, traders are eyeing volume—will it stay up now that trading has resumed? Another question: can the stock keep its footing above today’s lows? Over the coming week, everything points to progress on a board final investment decision, something the company is aiming for in the second half of 2026. Sunrise has tied that to site works beginning in the back half of 2026 and a first-half 2028 commissioning target for the initial 60-tonne-a-year line.

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Stock Market Today

  • Rambus Attracts Bullish Analyst Calls; 12-Month Price Target at $109.40
    July 21, 2026, 9:02 AM EDT. Rambus (NASDAQ:RMBS) is drawing increased interest from Wall Street, with Benchmark and Rosenblatt both assigning Buy ratings and price targets of $165. 24/7 Wall St. puts the 12-month price target at $109.40, suggesting an 8.48% potential gain. Although the stock has retreated 28.56% since its $174.10 June peak, it remains up 47.85% for the year. Rambus exceeded expectations in Q1 2026, posting $180.19M in revenue on strong AI memory chip demand. The CEO points to expanding AI workloads as a driver for greater memory bandwidth requirements.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 03.03.2026

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
Next Story

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom

Go toTop